Influences of the p53 Status on Hypoxia-induced Gene Expression

作者: Junye LIU , Toru SHIBATA , Runjiang Qu , Masakazu OGURA , Masahiro HIRAOKA

DOI: 10.1269/JRR.45.333

关键词:

摘要: The p53 tumor-suppressor gene is one of the most frequently mutated genes in human cancers, and its genetic alterations may play critical roles oncogenesis, tumor progression, angiogenesis. To clarify influence status on hypoxia-inducible expression, we first performed transfection assays with a hypoxia-responsive vector carrying 5 elements upstream CMV minimal promoter driving transcription luciferase various cell lines wild-type (wt) or mutant (mut) p53. As result, hypoxia responsiveness considerably varied between lines, could not obtain clear evidence that factor-1 (HIF-1) mediated expression wt-p53 cells was lower than mut-p53. It interesting SaOS2 (p53 null) showed highest activities under both aerobic hypoxic conditions among tested cells. Next, to elucidate effects endogenous wt- mut-p53s, assay Northern blot analysis for VEGF were by using isogenic variants HT1080 differing their status. mRNA apparently variant mutations alleles parental line harboring wt-p53, implying some types constitutively accumulated can decrease basal hypoxia-induced expressions addition wt-p53.

参考文章(36)
Georg Oberhuber, Peter Birner, Gerhard Breitenecker, Monika Schindl, Andreas Obermair, Christina Plank, Overexpression of Hypoxia-inducible Factor 1α Is a Marker for an Unfavorable Prognosis in Early-Stage Invasive Cervical Cancer Cancer Research. ,vol. 60, pp. 4693- 4696 ,(2000)
Faton Agani, David G. Kirsch, Gregg L. Semenza, Scott L. Friedman, Michael B. Kastan, p53 Does Not Repress Hypoxia-induced Transcription of the Vascular Endothelial Growth Factor Gene Cancer Research. ,vol. 57, pp. 4474- 4477 ,(1997)
Dominic A. Scudiero, Kurt W. Kohn, John N. Weinstein, Stephen Friend, Joany Jackman, Albert J. Fornace, Timothy G. Myers, Masato Mutoh, Edward A. Sausville, Saijun Fan, Ann Monks, Patrick M. O'Connor, Insoo Bae, Characterization of the p53 Tumor Suppressor Pathway in Cell Lines of the National Cancer Institute Anticancer Drug Screen and Correlations with the Growth-Inhibitory Potency of 123 Anticancer Agents Cancer Research. ,vol. 57, pp. 4285- 4300 ,(1997)
Won G. An, Meera Kanekal, M. Celeste Simon, Emin Maltepe, Mikhail V. Blagosklonny, Leonard M. Neckers, Stabilization of wild-type p53 by hypoxia-inducible factor 1α Nature. ,vol. 392, pp. 405- 408 ,(1998) , 10.1038/32925
Leonidas Tsiokas, Vikas P. Sukhatme, Debabrata Mukhopadhyay, Wild-Type p53 and v-Src Exert Opposing Influences on Human Vascular Endothelial Growth Factor Gene Expression Cancer Research. ,vol. 55, pp. 6161- 6165 ,(1995)
A J Giaccia, J M Brown, The unique physiology of solid tumors: opportunities (and problems) for cancer therapy Cancer Research. ,vol. 58, pp. 1408- 1416 ,(1998)
Mikhail V. Blagosklonny, Won G. An, Larisa Y. Romanova, Jane Trepel, Tito Fojo, Len Neckers, p53 Inhibits Hypoxia-inducible Factor-stimulated Transcription * Journal of Biological Chemistry. ,vol. 273, pp. 11995- 11998 ,(1998) , 10.1074/JBC.273.20.11995
U. Santhanam, A. Ray, P. B. Sehgal, Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 88, pp. 7605- 7609 ,(1991) , 10.1073/PNAS.88.17.7605
H. Masuda, C. Miller, H. P. Koeffler, H. Battifora, M. J. Cline, Rearrangement of the p53 gene in human osteogenic sarcomas. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 7716- 7719 ,(1987) , 10.1073/PNAS.84.21.7716
Arnold J Levine, p53, the Cellular Gatekeeper for Growth and Division Cell. ,vol. 88, pp. 323- 331 ,(1997) , 10.1016/S0092-8674(00)81871-1